WHO ICTRP trial
VEGF-D gene therapy in severe coronary artery disease. Phase II clinical trial…
CTIS2024-512255-20-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-512255-20-00 |
|---|---|
| Public title | VEGF-D gene therapy in severe coronary artery disease. Phase II clinical trial (ReGenHeart). |
| Scientific title | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled study. - RGH201 |
| Primary sponsor | Pohjois-Savon hyvinvointialue |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | United Kingdom;Denmark;Finland |
| Conditions | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost- effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled study.;Therapeutic area: Diseases [C]… |
| Interventions | Product Name: AdsVEGF-D Delta N Delta C, Product Code:PRD11250995, Pharmaceutical Form: INJECTION, Other descriptive name: , Strength: , Product Name: Placebo to AdsVEGF-D Delta N Delta C test product, Product Code:N/A, Pharmaceutical Form… |
| Registration date | Apr 22, 2024 |
| Target size | 45 |
| Secondary IDs | NCT03039751;2017-000789-31 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: